Clinical Trial Update: Fish Oil for Patients With Liver Disease Due to Parenteral Nutrition [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating fish oil for liver disease due to parenteral nutrition has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Parenteral Nutrition-induced Cholestasis

Drugs mentioned

• Fish oil

Snippet

Sponsor: Johane Allard | Conditions: Total Parenteral Nutrition-induced Cholestasis | Phase 3 | Status: TERMINATED